The Trump administration has issued numerous pharma-focused executive orders, including “Lowering Drug Prices by Once Again Putting Americans ...

New York hospitals that get discounted drugs through a controversial federal program are gearing up for a new pilot that they ...

From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment ...

Q2 2025 Management View CEO Laura E. Niklason reported significant expansion in commercial access for Symvess, following its FDA approval for extremity vascular trauma, stating, "a total of 13 ...